DEFINITION OF FUNCTIONAL SITES ON COAGULATION FACTOR X
DEFINITION OF FUNCTIONAL SITES ON COAGULATION FACTOR X
批准号:
3471961
负责人:
William R Church
金额:
$9.85万
依托单位国家:
美国
项目类别:
财政年份:
1989
资助国家:
美国
项目状态:
已结题
起止时间:
1989-07-01 至 1994-06-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Both the intrinsic and extrinsic coagulation pathways terminate
with the activation of the blood protein Factor X. Activated
Factor X in turn forms a supramolecular complex, termed
prothrombinase, consisting of an enzyme (Factor X alpha), a protein
cofactor (Factor V alpha), calcium ion, and a phospholipid surface.
This assembled complex catalyzes the proteolytic activation of
prothrombin to the protease thrombin. The expedient formation of
thrombin at wound sites thus requires the precise recognition and
binding of the enzyme to a cofactor, a surface, and a substrate.
Each of these interactions is mediated by distinct regions on the
surface of Factor X. The approach outlined in this proposal will
define those peptide sites on Factor X involved in recognition and
binding to prothrombin, Factor V alpha, and phospholipid. The
approach is to use isolated peptide fragments of Factor X,
synthetic peptides from the known sequence of Factor X, and
antibodies to specific topographic sites on Factor X in well-
defined functional assays for Factor X. Peptides that will be
synthesized include the variable region sequences of Factor X and
sequences from the Gla domain. Several available monoclonal
antibodies will be examined for their ability to inhibit Factor X
activity and the antigenic determinant recognized by the inhibitory
antibody alpha Beta F chi-2 beta will be localized. Antibodies
produced to the synthetic peptides will also be examined for their
ability to bind Factor X and to inhibit prothrombin activation,
prothrombinase complex assembly or Factor X binding to phospholipid
vesicles. This combined approach on the structure/function of
Factor X using peptide fragments, synthetic peptides, and site-
specific antibodies will provide more information about the
relevant surface features of the Factor X molecule important for
its function than would each approach used separately. Such
topographic information will be extremely valuable in understanding
the assembly, function, and regulation of prothrombinase, and at
the same time, assist the design and modification of genetically
engineered blood coagulation proteins.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DEFINITION OF FUNCTIONAL SITES ON COAGULATION FACTOR X
-
批准号:3471960
-
项目类别:
-
资助金额:$9.62万
-
财政年份:1989
-
负责人:William R Church
-
依托单位:
DEFINITION OF FUNCTIONAL SITES ON COAGULATION FACTOR X
-
批准号:3471959
-
项目类别:
-
资助金额:$10.06万
-
财政年份:1989
-
负责人:William R Church
-
依托单位:
DEFINITION OF FUNCTIONAL SITES ON COAGULATION FACTOR X
-
批准号:3471962
-
项目类别:
-
资助金额:$10.97万
-
财政年份:1989
-
负责人:William R Church
-
依托单位:
DEFINITION OF FUNCTIONAL SITES ON COAGULATION FACTOR X
-
批准号:3471963
-
项目类别:
-
资助金额:$11.39万
-
财政年份:1989
-
负责人:William R Church
-
依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
-
批准号:2022J011295
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:王亚伟
-
依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
-
批准号:30801055
-
项目类别:青年科学基金项目
-
资助金额:19.0万元
-
批准年份:2008
-
负责人:王丽梅
-
依托单位: